$10.14
-0.1-0.98%
At close: -
$10.21
0.070.69%
After Hours: Nov 22, 7:50 PM EDT
Comments
Loading...
Arcutis Biotherapeutics (ARQT) Forecast
NewsEarningsArcutis Biotherapeutics (ARQT) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestArcutis Biotherapeutics (NASDAQ:ARQT) Stock Quotes, Forecast and News Summary
Arcutis Biotherapeutics Stock (NASDAQ: ARQT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Arcutis Biotherapeutics (ARQT) stock?
You can purchase shares of Arcutis Biotherapeutics (NASDAQ:ARQT) through any online brokerage.
Who are Arcutis Biotherapeutics (ARQT) competitors?
Other companies in Arcutis Biotherapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT) and Upstream Bio (NASDAQ:UPB).
What is the forecast, or price target, for Arcutis Biotherapeutics (ARQT) stock?
Arcutis Biotherapeutics has a consensus price target of $25.90.
What is the current price for Arcutis Biotherapeutics (ARQT)?
The stock price for Arcutis Biotherapeutics (NASDAQ: ARQT) is $10.21 last updated November 22, 2024 at 7:50 PM EST.
Does Arcutis Biotherapeutics (ARQT) pay a dividend?
There are no upcoming dividends for Arcutis Biotherapeutics.
When is Arcutis Biotherapeutics (NASDAQ:ARQT) reporting earnings?
Arcutis Biotherapeutics’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
Is Arcutis Biotherapeutics (ARQT) going to split?
There is no upcoming split for Arcutis Biotherapeutics.
What sector and industry does Arcutis Biotherapeutics (ARQT) operate in?
Arcutis Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.